Medtronic InterStim On Track For Medicare Coverage After MCAC Review
This article was originally published in The Gray Sheet
Executive Summary
The Medicare Coverage Advisory Committee's Medical/Surgical Procedures panel gave wide discretion to the Health Care Financing Administration to determine whether Medtronic's InterStim sacral nerve stimulation (SNS) device for urinary incontinence should be reimbursed prior to, or following, surgery.